Bioactivation of latent transforming growth factor β1 by Mycobacterium tuberculosis in human mononuclear phagocytes
Bioactivation of latent transforming growth factor β1 by Mycobacterium tuberculosis in human mononuclear phagocytes
复制标题
DOI:
10.1111/j.1365-3083.2005.01623.x
复制
发表时间:
2005-06-01
影响因子:
3.7
通讯作者:
Toossi, Z
中科院分区:
文献类型:
--
作者:
Aung, H;Wu, M;Toossi, Z
Biologically active transforming growth factor beta 1 (TGF beta 1) has been identified at sites of Mycobacterium tuberculosis (MTB) infection in the lung; however, the underlying mechanism(s) for its activation is not clear. Here using an enzyme-linked immunospot assay for TGF beta 1, we show that human blood monocytes (MN) and alveolar macrophages (AM) produce bioactive TGF beta 1 upon stimulation by MTB. However, only MTB-stimulated MN increased TGF beta 1 production on a per cell basis. The frequency of TGF beta 1-producing MN was reduced by an inhibitor of plasmin, bdellin, indicating a role for plasmin pathways in the bioactivation of cytokine. The expression of urokinase plasminogen activator receptor (uPAR) mRNA and both surface and soluble uPAR (CD87) was increased in MTB-activated MN. However, antibody neutralization of uPAR suppressed bioactive TGF beta 1 in MN alone. Thus, the more immature MN, which are continuously recruited to the lung during tuberculosis (TB), have a higher capacity to bioactivate TGF beta 1 by expression of components of the plasmin pathway. Excess production and bioactivation of TGF beta 1 at sites of MTB infection may undermine host immune responses during TB.